Evotec SE Statistics
Total Valuation
Evotec SE has a market cap or net worth of $1.34 billion. The enterprise value is $1.47 billion.
Important Dates
The last earnings date was Wednesday, August 13, 2025, before market open.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Evotec SE has 177.56 million shares outstanding. The number of shares has increased by 0.23% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 177.56M |
| Shares Change (YoY) | +0.23% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 130.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.47 |
| Forward PS | 3.06 |
| PB Ratio | 1.35 |
| P/TBV Ratio | 2.10 |
| P/FCF Ratio | 35.80 |
| P/OCF Ratio | 10.21 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 154.00, with an EV/FCF ratio of 39.38.
| EV / Earnings | n/a |
| EV / Sales | 1.61 |
| EV / EBITDA | 154.00 |
| EV / EBIT | n/a |
| EV / FCF | 39.38 |
Financial Position
The company has a current ratio of 1.58, with a Debt / Equity ratio of 0.55.
| Current Ratio | 1.58 |
| Quick Ratio | 1.35 |
| Debt / Equity | 0.55 |
| Debt / EBITDA | 15.58 |
| Debt / FCF | 14.52 |
| Interest Coverage | -4.97 |
Financial Efficiency
Return on equity (ROE) is -16.75% and return on invested capital (ROIC) is -3.27%.
| Return on Equity (ROE) | -16.75% |
| Return on Assets (ROA) | -2.40% |
| Return on Invested Capital (ROIC) | -3.27% |
| Return on Capital Employed (ROCE) | -5.12% |
| Revenue Per Employee | $192,594 |
| Profits Per Employee | -$38,534 |
| Employee Count | 4,740 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 18.83 |
Taxes
In the past 12 months, Evotec SE has paid $22.92 million in taxes.
| Income Tax | 22.92M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +29.63% in the last 52 weeks. The beta is 1.10, so Evotec SE's price volatility has been similar to the market average.
| Beta (5Y) | 1.10 |
| 52-Week Price Change | +29.63% |
| 50-Day Moving Average | 4.07 |
| 200-Day Moving Average | 4.14 |
| Relative Strength Index (RSI) | 42.46 |
| Average Volume (20 Days) | 78,125 |
Short Selling Information
| Short Interest | 667,520 |
| Short Previous Month | 650,877 |
| Short % of Shares Out | 0.19% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 7.56 |
Income Statement
In the last 12 months, Evotec SE had revenue of $912.89 million and -$182.65 million in losses. Loss per share was -$1.03.
| Revenue | 912.89M |
| Gross Profit | 117.67M |
| Operating Income | -85.71M |
| Pretax Income | n/a |
| Net Income | -182.65M |
| EBITDA | 9.55M |
| EBIT | -85.71M |
| Loss Per Share | -$1.03 |
Full Income StatementBalance Sheet
The company has $408.69 million in cash and $542.66 million in debt, giving a net cash position of -$133.97 million or -$0.75 per share.
| Cash & Cash Equivalents | 408.69M |
| Total Debt | 542.66M |
| Net Cash | -133.97M |
| Net Cash Per Share | -$0.75 |
| Equity (Book Value) | 993.29M |
| Book Value Per Share | 5.59 |
| Working Capital | 259.85M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $131.02 million and capital expenditures -$93.50 million, giving a free cash flow of $37.37 million.
| Operating Cash Flow | 131.02M |
| Capital Expenditures | -93.50M |
| Free Cash Flow | 37.37M |
| FCF Per Share | $0.21 |
Full Cash Flow StatementMargins
Gross margin is 12.89%, with operating and profit margins of -9.39% and -20.01%.
| Gross Margin | 12.89% |
| Operating Margin | -9.39% |
| Pretax Margin | -17.50% |
| Profit Margin | -20.01% |
| EBITDA Margin | 1.05% |
| EBIT Margin | -9.39% |
| FCF Margin | 4.09% |
Dividends & Yields
Evotec SE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.23% |
| Shareholder Yield | -0.23% |
| Earnings Yield | -13.65% |
| FCF Yield | 2.79% |
Dividend DetailsAnalyst Forecast
The average price target for Evotec SE is $5.40, which is 42.48% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.40 |
| Price Target Difference | 42.48% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 9.75% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 20, 2021. It was a forward split with a ratio of 4:1.
| Last Split Date | Oct 20, 2021 |
| Split Type | Forward |
| Split Ratio | 4:1 |
Scores
Evotec SE has an Altman Z-Score of 0.68 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.68 |
| Piotroski F-Score | 4 |